Financial Performance - Net sales for Q3 2024 increased by $14 million (or 1%) to $1.5 billion compared to Q3 2023, driven by a 5% increase in volume, despite a 3% decrease in price and a 1% unfavorable currency impact [300]. - For the nine months ended September 30, 2024, net sales decreased by $278 million (or 6%) to $4.4 billion, primarily due to a 5% decrease in price and a 1% headwind from the sale of the Glycolic Acid business in 2023 [301]. - The Thermal & Specialized Solutions segment's net sales increased by $24 million (6%) to $460 million for the three months ended September 30, 2024, compared to $436 million for the same period in 2023 [321]. - The Titanium Technologies segment's net sales decreased by $11 million (2%) to $679 million for the three months ended September 30, 2024, compared to $690 million for the same period in 2023 [327]. - For the nine months ended September 30, 2024, segment net sales decreased by $133 million (12%) to $985 million, down from $1.1 billion in the same period in 2023 [335]. - Net sales for the nine months ended September 30, 2024, were $3.1 billion, with a gross profit of $428 million and net income of $27 million [378]. Cost and Expenses - Cost of goods sold (COGS) remained flat at $1.2 billion for Q3 2024, while COGS for the nine months decreased by $105 million (or 3%) to $3.5 billion, attributed to lower raw materials costs [303]. - Selling, general, and administrative (SG&A) expenses decreased by $30 million (or 18%) to $135 million for Q3 2024, and by $651 million (or 61%) to $416 million for the nine months, mainly due to reduced litigation-related charges [304]. - Research and development (R&D) expenses were relatively stable at $29 million for Q3 2024 and $83 million for the nine months, compared to $28 million and $82 million in the same periods of 2023 [305]. - Corporate and Other costs increased by $3 million (6%) to $57 million for the three months ended September 30, 2024, compared to $54 million in the same period in 2023 [338]. Impairments and Charges - The company recorded a non-cash goodwill impairment charge of $56 million in Q3 2024 for the Advanced Performance Materials reporting unit [294]. - A goodwill impairment charge of $56 million was recognized for the Advanced Performance Materials reporting unit for the three and nine months ended September 30, 2024 [308]. - The company recorded non-cash asset-related charges of $25 million in Q3 2024 related to the write-off of certain operating assets as part of strategic footprint transformation initiatives [385]. - Restructuring, asset-related, and other charges decreased by $81 million (or 64%) to $45 million for Q3 2024, and by $89 million (or 63%) to $52 million for the nine months, primarily due to the 2024 Restructuring Program [306]. Cash Flow and Liquidity - As of September 30, 2024, total unrestricted cash and cash equivalents were $596 million, with $394 million held by foreign subsidiaries [342]. - The availability under the Revolving Credit Facility as of September 30, 2024, was $652 million, net of $49 million in outstanding letters of credit [342]. - For the nine months ended September 30, 2024, the company incurred a net cash usage of $771 million in operating activities, compared to a cash provided of $74 million in the same period of 2023 [346]. - The company utilized supply chain financing to accelerate the collection of $40 million and $95 million in accounts receivable for the quarters ended September 30, 2024 and 2023, respectively [349]. - The company expects to fund significant cash payments for known obligations through cash generated from operations and existing debt financing arrangements [352]. Environmental and Sustainability Commitments - The company is committed to sustainability and has set ambitious Corporate Responsibility Commitment goals to achieve by 2030, focusing on reducing greenhouse gas emissions and environmental impact [292]. - The company aims for a 60% reduction in Scope 1 and Scope 2 absolute GHG emissions by 2030, aligning with its Environmental Leadership goals [426]. - Chemours has set a target to achieve net zero greenhouse gas emissions from its operations by 2050, with near-term science-based targets approved by the Science Based Targets initiative (SBTi) [427]. - The company expects to spend approximately $160 million over the next three years on the five most significant remediation sites, which represent 80% of total accrued liabilities [402]. Foreign Currency and Interest Rate Management - As of September 30, 2024, the company had 9 foreign currency forward contracts outstanding with an aggregate gross notional U.S. dollar equivalent of $153 million, with a fair value of less than $1 million [443]. - The company recognized a net gain of $1 million and a net loss of $5 million for the three and nine months ended September 30, 2024, respectively, related to non-designated foreign currency forward contracts [443]. - The company entered into interest rate swaps with an aggregate notional U.S. dollar equivalent of $300 million, with a fair value of negative $8 million as of September 30, 2024 [447]. - Pre-tax losses of $6 million and less than $1 million were recognized for the three and nine months ended September 30, 2024, respectively, related to interest rate swaps [447]. Remediation and Legal Matters - The company has $567 million in environmental remediation liabilities as of September 30, 2024, with $119 million classified as current liabilities [352]. - Fayetteville Works has been under investigation for PFAS releases, with a Consent Order in place requiring the company to provide permanent replacement drinking water supplies to affected residents [409]. - The estimated potential liabilities for environmental remediation may range up to approximately $710 million above the accrued amount as of September 30, 2024, reflecting inherent uncertainties in evaluations [397]. - The U.S. Smelter and Lead Refinery site in East Chicago, Indiana, is under EPA-directed remediation, with the company cooperating with multiple parties [413].

EXHIBIT 99.1 Wilmington, Del., November 4, 2024 – The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global leader in delivering innovative performance chemistry through Thermal & Specialized Solutions ("TSS"), Titanium Technologies ("TT"), and Advanced Performance Materials ("APM"), today announced its financial results for the third quarter 2024 and provided an update on the Company's corporate strategy. Key Third Quarter 2024 Results & Highlights • Net Sales of $1.5 billion, in line with th ...

Chemours (CC) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The earnings report, which is expected to be released on November 4, 2024, might help the stock move higher if these key numbers are better than exp ...

The Chemours Company (CC) has announced that it is developing a low global warming potential (GWP) refrigerant retrofit strategy for the automotive aftermarket to help support the global phaseout of higher GWP hydrofluorocarbon (HFC) refrigerants. The technical approach will allow car owners and service professionals with a simple retrofit process to safely and cost-effectively replace the legacy R-134a refrigerant in their existing vehicle with the widely used, low GWP Opteon YF refrigerant. Opteon YF was ...

JHVEPhoto Dear readers/followers, When I last covered Chemours (NYSE:CC) the company had seen some irregularities in its operations in accounting. In my last article, I saw a positive rate of return for the investment I made a few months prior - and the current rate of return from that article is barely negative here - but since my last piece, the stock is actually down a bit over 10%. In this article, we'll look at the longer-term implications and background of this move. I've long owned Chemours, unfortun ...

The Chemours Company (CC) recently announced the opening of the Chemours Battery Innovation Center (CBIC), a state-of-the-art laboratory facility located at the Chemours Discovery Hub in Newark, DE. This multi-million-dollar investment aims to support the testing and scaling of next-generation battery technologies, ultimately enabling more sustainable, cost-effective, energy-efficient and high-performing batteries for hybrid and electric vehicles (EVs). Chemours, which is among prominent players in the chem ...

NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE: CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC. Investigation Details On August 1, 2024, Chemours reported its financial results for the second quarter of 2024. The Com ...

The Chemours Company (NYSE:CC) Q2 2024 Earnings Conference Call August 2, 2024 8:00 AM ET Company Participants Brandon Ontjes - VP of IR Denise Dignam - President and CEO Shane Hostetter - SVP, CFO & Principal Accounting Officer Conference Call Participants John McNulty - BMO Capital Markets Mike Leithead - Barclays John Roberts - Mizuho Josh Spector - UBS Financial Hassan Ahmed - Alembic Global Advisors Laurence Alexander - Jefferies Arun Viswanathan - RBC Capital Markets Vincent Andrews - Morgan Stanley J ...

Second Quarter 2024 Earnings Presentation August 1, 2024 Safe Harbor Statement and Other Matters 2 We prepare our financial statements in accordance with Generally Accepted Accounting Principles (GAAP). Within this press release, we may make reference to Adjusted Net Income, Adjusted EPS, Adjusted EBITDA, Total Debt Principal, Net and Net Leverage Ratio which are non-GAAP financial measures. The Company includes these non-GAAP financial measures because management believes they are useful to investors in th ...

For the quarter ended June 2024, Chemours (CC) reported revenue of $1.54 billion, down 6.4% over the same period last year. EPS came in at $0.38, compared to $1.10 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $1.54 billion, representing a surprise of +0.01%. The company delivered an EPS surprise of -42.42%, with the consensus EPS estimate being $0.66. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expe ...